Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins

Bioorganic & Medicinal Chemistry
2013.0

Abstract

This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.

Knowledge Graph

Similar Paper

Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins
Bioorganic & Medicinal Chemistry 2013.0
New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
Journal of Medicinal Chemistry 2012.0
Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer
Journal of Medicinal Chemistry 2021.0
Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents
Journal of Medicinal Chemistry 2010.0
Synthesis and evaluation of the anticancer activity of some semisynthetic derivatives of rutaecarpine and evodiamine
Synthetic Communications 2021.0
Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents
Journal of Medicinal Chemistry 2015.0
Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents
Bioorganic & Medicinal Chemistry 2022.0
Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer
Journal of Medicinal Chemistry 2020.0
Evodiamine: A Privileged Structure with Broad-ranging Biological Activities
Mini-Reviews in Medicinal Chemistry 2022.0
Design, synthesis, and biological evaluation of benzenesulfonyl chloride-substituted evodiamine derivatives as potential PGAM1 inhibitors
Arabian Journal of Chemistry 2023.0